Deprecated: Creation of dynamic property Disable_Comments::$is_CLI is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\disable-comments.php on line 59

Deprecated: Creation of dynamic property Disable_Comments::$sitewide_settings is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\disable-comments.php on line 61

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_uris is deprecated in D:\www\pep\blog\wp-content\plugins\permalink-manager\permalink-manager.php on line 137

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_permastructs is deprecated in D:\www\pep\blog\wp-content\plugins\permalink-manager\permalink-manager.php on line 138

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_redirects is deprecated in D:\www\pep\blog\wp-content\plugins\permalink-manager\permalink-manager.php on line 139

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_external_redirects is deprecated in D:\www\pep\blog\wp-content\plugins\permalink-manager\permalink-manager.php on line 140

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_alerts is deprecated in D:\www\pep\blog\wp-content\plugins\permalink-manager\permalink-manager.php on line 145

Deprecated: Creation of dynamic property SEOPress\Actions\Admin\Importer\AIO::$tagsAIO is deprecated in D:\www\pep\blog\wp-content\plugins\wp-seopress\src\Actions\Admin\Importer\AIO.php on line 12

Deprecated: Creation of dynamic property SEOPress\Actions\Admin\Importer\RankMath::$tagsRankMath is deprecated in D:\www\pep\blog\wp-content\plugins\wp-seopress\src\Actions\Admin\Importer\RankMath.php on line 12

Deprecated: Creation of dynamic property SEOPress\Actions\Front\Metas\DescriptionMeta::$tagsToStringService is deprecated in D:\www\pep\blog\wp-content\plugins\wp-seopress\src\Actions\Front\Metas\DescriptionMeta.php on line 11

Deprecated: Creation of dynamic property SEOPress\Actions\Front\Metas\TitleMeta::$tagsToStringService is deprecated in D:\www\pep\blog\wp-content\plugins\wp-seopress\src\Actions\Front\Metas\TitleMeta.php on line 11

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$disabled_wp_cron is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 69

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$enable_self_cron is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 70

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$require_optin is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 74

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$include_goodbye_form is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 75

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$marketing is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 76

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$options is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 77

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$item_id is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 78

Deprecated: Creation of dynamic property Disable_Comments::$tracker is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\disable-comments.php on line 149

Deprecated: Creation of dynamic property DisableComments_Plugin_Tracker::$notice_options is deprecated in D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php on line 657

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752

Warning: Cannot modify header information - headers already sent by (output started at D:\www\pep\blog\wp-content\plugins\disable-comments\includes\class-plugin-usage-tracker.php:78) in D:\www\pep\blog\wp-includes\rest-api\class-wp-rest-server.php on line 1752
{"id":1096,"date":"2025-04-24T03:33:24","date_gmt":"2025-04-24T08:33:24","guid":{"rendered":"https:\/\/www.creative-peptides.com\/blog\/?p=1096"},"modified":"2025-05-15T01:50:21","modified_gmt":"2025-05-15T06:50:21","slug":"representative-peptides-for-in-vivo-imaging","status":"publish","type":"post","link":"https:\/\/www.creative-peptides.com\/blog\/representative-peptides-for-in-vivo-imaging\/","title":{"rendered":"Representative Peptides for In Vivo<\/em>\u00a0Imaging"},"content":{"rendered":"\n

The biological activity of peptides is regulated through their binding to corresponding receptors. Peptides that target receptors overexpressed on tumor cells\u2014but not on normal cells\u2014are excellent candidates for in vivo<\/em> tumor imaging. To date, many peptides and their analogs have been identified for disease detection. Some representative peptides are summarized below:<\/p>\n\n\n\n

1. RGD<\/p>\n\n\n\n

The tripeptide RGD can specifically bind to integrin receptors. Integrins are composed of two subunits (\u03b1 and \u03b2). The integrin family, especially \u03b1V\u03b23, plays a crucial role in tumor angiogenesis and metastasis. During angiogenesis, these receptors are overexpressed on endothelial cells but are barely detectable in most normal organs. Therefore, they are widely used in diagnostic imaging.<\/p>\n\n\n\n

Single-letter code: H2N-RGD-OH<\/p>\n\n\n\n

Three-letter code: H2N-Arg-Gly-Asp-OH<\/p>\n\n\n\n

Number of amino acids: 3<\/p>\n\n\n\n

Molecular formula: C12H22N6O6<\/p>\n\n\n\n

Average molecular weight (MW): 346.34<\/p>\n\n\n\n

RGD Peptides<\/a><\/p>\n\n\n\n

CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td>CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td><\/tr>
R04002<\/td>TP508, Thrombin-derived Peptide<\/a><\/td>R04043<\/td>H-Arg-Phe-Asp-Ser-OH<\/a><\/td><\/tr>
R04003<\/td>GRGDS, amide<\/a><\/td>R04044<\/td>H-Asp-Arg-Gly-Asp-Ser-OH<\/a><\/td><\/tr>
R04004<\/td>RGDfV<\/a><\/td>R04045<\/td>H-Asp-Arg-Leu-Asp-Ser-OH<\/a><\/td><\/tr>
R04007<\/td>GRGDTP<\/a><\/td>R04046<\/td>H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH<\/a><\/td><\/tr>
R04008<\/td>GRGESP<\/a><\/td>R04047<\/td>H-D-Arg-Gly-Asp-Trp-OH<\/a><\/td><\/tr>
R04011<\/td>GRADSPK<\/a><\/td>R04048<\/td>H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH<\/a><\/td><\/tr>
R04012<\/td>RGDyK<\/a><\/td>R04049<\/td>H-Gly-Arg-Ala-Asp-Ser-Pro-OH<\/a><\/td><\/tr>
R04013<\/td>RGDyC<\/a><\/td>R04050<\/td>H-Gly-Arg-Asp-Gly-Ser-OH<\/a><\/td><\/tr>
R04015<\/td>RADyK<\/a><\/td>R04052<\/td>H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH<\/a><\/td><\/tr>
R04016<\/td>E(RGDyK)2<\/a><\/td>R04053<\/td>H-Gly-Arg-Gly-Asp-OH<\/a><\/td><\/tr>
R04017<\/td>RGD – 4C<\/a><\/td>R04054<\/td>H-Gly-Arg-Gly-Asp-Ser-Cys-OH<\/a><\/td><\/tr>
R04018<\/td>Prototype of RGD – containing peptide, FITC – labeled<\/a><\/td>R04059<\/td>H-Gly-Arg-Gly-Asp-Thr-Pro-OH<\/a><\/td><\/tr>
R04020<\/td>Ac-Asp-Arg-Gly-Asp-Ser-OH<\/a><\/td>R04060<\/td>H-Gly-Arg-Gly-Glu-Ser-OH<\/a><\/td><\/tr>
R04022<\/td>Ac-Pen-Arg-Gly-Asp-Cys-OH<\/a><\/td>R04061<\/td>H-Gly-Arg-Gly-Glu-Ser-Pro-OH<\/a><\/td><\/tr>
R04023<\/td>Bifunctional Antiplatelet Agent<\/a><\/td>R04062<\/td>H-Gly-Arg-Gly-Glu-Thr-Pro-OH<\/a><\/td><\/tr>
R04024<\/td>Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl)<\/a><\/td>R04063<\/td>H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH<\/a><\/td><\/tr>
R04025<\/td>Cyclo(-Arg-Ala-Asp-D-Phe-Cys)<\/a><\/td>R04064<\/td>H-Gly-Phe-Arg-Gly-Asp-Gly-Gln-OH<\/a><\/td><\/tr>
R04027<\/td>Cyclo(-Arg-Ala-Asp-D-Phe-Val)<\/a><\/td>R04065<\/td>H-Lys-Gly-Asp-Ser-OH<\/a><\/td><\/tr>
R04031<\/td>Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) sulfoxide<\/a><\/td>R04066<\/td>H-Lys-Gly-Glu-OH<\/a><\/td><\/tr>
R04032<\/td>Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala)<\/a><\/td>R04069<\/td>retro-Arg-malonyl-Asp-OH<\/a><\/td><\/tr>
R04033<\/td>Eptifibatide<\/a><\/td>R04070<\/td>Sar-Arg-Gly-Asp-Ser-Pro-OH<\/a><\/td><\/tr>
R04035<\/td>H-Ala-Pro-Arg-Gly-Asp-OH<\/a><\/td>R04071<\/td>Gly double addition eptifibatide<\/a><\/td><\/tr>
R04036<\/td>H-Arg-Arg-Gly-Asp-Met-Glu-OH<\/a><\/td>R04072<\/td>d-Asp eptifibatide<\/a><\/td><\/tr>
R04040<\/td>H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH<\/a><\/td>R04073<\/td>D-Pro(6) Eptifibatide<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

2. Bombesin (BBN) \/ Gastrin-Releasing Peptide (GRP)<\/p>\n\n\n\n

BBN and its related peptides from amphibians form a neuropeptide family with multiple physiological effects, such as exocrine and endocrine secretion, thermoregulation, sucrose regulation, and cell growth. Bombesin-like peptide receptors have four subtypes: neuromedin B receptor, bombesin receptor subtype 3, gastrin-releasing peptide receptor (GRPR), and bombesin receptor subtype 4. These receptors are overexpressed in various tumors, including breast cancer, ovarian cancer, and gastrointestinal stromal tumors.<\/p>\n\n\n\n

Bombesin and Analogs<\/a><\/p>\n\n\n\n

CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td><\/tr>
B07004<\/td>Bombesin (8-14)<\/a><\/td><\/tr>
B07010<\/td>[Lys3]-Bombesin<\/a><\/td><\/tr>
B07011<\/td>[Tyr4, D-Phe12]-Bombesin<\/a><\/td><\/tr>
B07015<\/td>(D-Cys6,Asn7,D-Ala11,Cys14)-Bombesin (6-14)<\/a><\/td><\/tr>
B07016<\/td>(D-Phe12)-Bombesin<\/a><\/td><\/tr>
B07017<\/td>(D-Phe12,Leu14)-Bombesin<\/a><\/td><\/tr>
B07019<\/td>(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14)<\/a><\/td><\/tr>
B07020<\/td>(D-Tyr6,betaPhe11,Phe13,Nle14)-Bombesin (6-14) (free acid)<\/a><\/td><\/tr>
B07022<\/td>(Tyr4)-Bombesin<\/a><\/td><\/tr>
B07023<\/td>Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu)<\/a><\/td><\/tr>
B07024<\/td>Biotin – Bombesin<\/a><\/td><\/tr>
B07025<\/td>Biotin – LC – LC – Bombesin<\/a><\/td><\/tr>
B07026<\/td>Bombesin, FAM – labeled<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Gastrin-Releasing Peptide (GRP)<\/a><\/p>\n\n\n\n

CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td>CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td><\/tr>
G03001<\/td>GRP (18-27) (human, porcine, canine)<\/a><\/td>G03027<\/td>Biotinyl-(Glu1)-Gastrin I (human) (phosphorylated)<\/a><\/td><\/tr>
G03002<\/td>Leptin (93-105), human<\/a><\/td>G03028<\/td>Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)<\/a><\/td><\/tr>
G03003<\/td>Gastrin Releasing Peptide (1-16), porcine<\/a><\/td>G03029<\/td>H-Trp-Met-Asn-Phe-NH2<\/a><\/td><\/tr>
G03004<\/td>Leptin (116-130), mouse.<\/a><\/td>G03031<\/td>(Deamino-Phe19,D-Ala24,D-Pro26-(R)-Phe27)-GRP (19-27) (human, porcine, canine)<\/a><\/td><\/tr>
G03005<\/td>Gastrin Releasing Peptide (1-16), human<\/a><\/td>G03032<\/td>H-Gly-Ser-Leu-Lys-Gln-Gln-Leu-Arg-Glu-Tyr-Ile-Arg-OH<\/a><\/td><\/tr>
G03007<\/td>Gastrin Releasing Peptide (14-27), porcine, human<\/a><\/td>G03033<\/td>Biotin-Gastrin (1-17)<\/a><\/td><\/tr>
G03009<\/td>Gastrin-Releasing Peptide (1-17)<\/a><\/td>G03016<\/td>Gastrin Releasing Peptide, human<\/a><\/td><\/tr>
G03010<\/td>(Leu15)-Gastrin-1, human<\/a><\/td>G03020<\/td>Gastrin, chicken<\/a><\/td><\/tr>
G03011<\/td>Gastrin-1, human<\/a><\/td>G03021<\/td>Gastrin Tetrapeptide, Gastrin (14-17), human<\/a><\/td><\/tr>
G03012<\/td>Gastrin derived peptide<\/a><\/td>G03022<\/td>Gastrin Tetrapeptide<\/a><\/td><\/tr>
G03013<\/td>Gastrin-1, rat<\/a><\/td>G03023<\/td>Acetyl-GRP (20-26) (human, porcine, canine)<\/a><\/td><\/tr>
G03014<\/td>Gastrin-1, human, sulfated (Gastrin II)<\/a><\/td>G03024<\/td>Acetyl-GRP (20-27) (human, porcine, canine)<\/a><\/td><\/tr>
G03015<\/td>Gastrin Releasing Peptide, porcine<\/a><\/td>G03026<\/td>Biotinyl-(Glu1)-Gastrin I (human)<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

3. Somatostatin (SST) Peptides<\/p>\n\n\n\n

Somatostatins (SSTs) are naturally occurring cyclic peptide hormones composed of either 14 or 28 amino acids. They inhibit the secretion of insulin, glucagon, and several other hormones. Their biological effects are mediated by binding to specific high-affinity somatostatin receptors (SSTRs), of which there are five subtypes: SSTR1 to SSTR5. These receptors are overexpressed in a variety of neuroendocrine tumors, such as pancreatic neuroendocrine tumors, small cell lung cancer, and thyroid carcinoma. Synthetic somatostatin analogs are widely used in imaging and therapy of tumors that express these receptors.<\/p>\n\n\n\n

Somatostatin & Analogs<\/a><\/p>\n\n\n\n

CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td><\/tr>
10-101-169<\/td>Pasireotide<\/a><\/td><\/tr>
10-101-26<\/td>Octreotide Acetate<\/a><\/td><\/tr>
10-101-44<\/td>Vapreotide Acetate<\/a><\/td><\/tr>
M34140635H<\/td>[Nal3]Octreotide acetate<\/a><\/td><\/tr>
M34140636H<\/td>TETA-Octreotide acetate<\/a><\/td><\/tr>
M34140637H<\/td>NOTA-Octreotide trifluoroacetate<\/a><\/td><\/tr>
M34140643H<\/td>DOTA-Lanreotide acetate<\/a><\/td><\/tr>
M34140653H<\/td>[Tyr3,Lys5(Boc)]octreotide acetate<\/a><\/td><\/tr>
M34140655H<\/td>[Lys5(Boc)]lanreotide acetate<\/a><\/td><\/tr>
O1003<\/td>([ring-D5]Phe3)-Octreotide<\/a><\/td><\/tr>
S07018<\/td>(D-2-Nal5,Cys6\u00b711,Tyr7,D-Trp8,Val10,2-Nal12)-Somatostatin-14 (5-12) amide<\/a><\/td><\/tr>
S07041<\/td>Tyr-(D-Dab4,Arg5,D-Trp8)-cyclo-Somatostatin-14 (4-11)<\/a><\/td><\/tr>
S07043<\/td>Vapreotide<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

4. Vasoactive Intestinal Peptide (VIP)<\/p>\n\n\n\n

VIP is a neuropeptide consisting of 28 amino acids. It not only promotes vasodilation but also stimulates cell growth and proliferation through cell surface receptor-mediated signaling pathways. Its effects are primarily regulated by two receptor subtypes, VPAC1 and VPAC2. VIP receptors are highly expressed in a variety of tumors, including but not limited to brain tumors, pancreatic adenocarcinomas, and neuroendocrine tumors. Notably, VIP is also considered a potential therapeutic agent; however, toxicity may occur even at sub-microgram doses.<\/p>\n\n\n\n

Single-letter sequence: H2N-HSDAVFTDNYTRLRKQMAVKKYLNSILN-OH<\/p>\n\n\n\n

Three-letter sequence: H2N-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-OH<\/p>\n\n\n\n

Number of amino acids: 28<\/p>\n\n\n\n

Molecular formula: C147H237N43O43S1<\/p>\n\n\n\n

Average molecular weight (MW): 3326.78<\/p>\n\n\n\n

Vasoactive Intestinal Peptides (VIPs)<\/a><\/p>\n\n\n\n

CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td>CAT#<\/strong><\/strong><\/td>Product Name<\/strong><\/strong><\/td><\/tr>
V02001<\/td>VIP Receptor Binding Inhibitor<\/a><\/td>V02024<\/td>VIP (1-12) human porcine rat<\/a><\/td><\/tr>
V02002<\/td>Prepro VIP\/PHM (111-122)<\/a><\/td>V02027<\/td>VIP Receptor-Binding Inhibitor L-8-K trifluoroacetate salt<\/a><\/td><\/tr>
V02004<\/td>(Pyr-16)-VIP (16-28) (chicken)<\/a><\/td>V1302<\/td>(Pyr16)-VIP (16-28) (chicken)<\/a><\/td><\/tr>
V02006<\/td>Prepro VIP\/PHM (156-170)<\/a><\/td>V1305<\/td>VIP sulfoxide (human, mouse, rat)<\/a><\/td><\/tr>
V02007<\/td>VIP (11-28), human, porcine, rat, ovine<\/a><\/td>V1307<\/td>(p-Chloro-D-Phe6,Leu17)-VIP (human, mouse, rat)<\/a><\/td><\/tr>
V02008<\/td>VIP (10-28), human, porcine, rat, ovine<\/a><\/td>V1309<\/td>(D-Phe2)-VIP (human, mouse, rat)<\/a><\/td><\/tr>
V02009<\/td>VIP (6-28) (human, bovine, porcine, rat)<\/a><\/td>V1310<\/td>VIP (guinea pig)<\/a><\/td><\/tr>
V02010<\/td>PHM-27\/PHI, human<\/a><\/td>V1312<\/td>Biotinyl-VIP (human, mouse, rat)<\/a><\/td><\/tr>
V02011<\/td>VIP (4-28) (human, bovine, porcine, rat)<\/a><\/td>V1313<\/td>(Ala11.22.28)-VIP (human, mouse, rat)<\/a><\/td><\/tr>
V02012<\/td>PHI-27 (porcine)<\/a><\/td>V1314<\/td>PHM-27 (human)<\/a><\/td><\/tr>
V02013<\/td>PHI-27 (rat)<\/a><\/td>V1315<\/td>(\u03b2-Asp3)-VIP (human, mouse, rat)<\/a><\/td><\/tr>
V02014<\/td>VIP (3-28) (human, bovine, porcine, rat)<\/a><\/td>V1320<\/td>Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)<\/a><\/td><\/tr>
V02015<\/td>[Ala11,22,28]-VIP (human, bovine, porcine, rat)<\/a><\/td>V1321<\/td>(Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)<\/a><\/td><\/tr>
V02016<\/td>VIP (human, bovine, porcine, rat)<\/a><\/td>V1322<\/td>Myristoyl-(Lys12.27.28)-VIP-Gly-Gly-Thr (free acid)<\/a><\/td><\/tr>
V02018<\/td>[Lys1, Pro2,5,Arg3,4,Tyr6] VIP, human, porcine, rat, ovine<\/a><\/td>V1323<\/td>Hexanoyl-(Ala19,Lys27.28)-VIP(free acid)<\/a><\/td><\/tr>
V02019<\/td>VIP (human, porcine, rat) FAM-labeled<\/a><\/td>V1325<\/td>Prepro VIP (156-170) (human)<\/a><\/td><\/tr>
V02020<\/td>[pGlu16]-VIP (16-28), porcine<\/a><\/td>V02022<\/td>Helodermin<\/a><\/td><\/tr>
V02021<\/td>Biotinyl-VIP (human, mouse, rat) trifluoroacetate salt<\/a><\/td>V02023<\/td>VIP-Lys(Biotin), human, porcine, rat<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n